GB9213901D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB9213901D0 GB9213901D0 GB929213901A GB9213901A GB9213901D0 GB 9213901 D0 GB9213901 D0 GB 9213901D0 GB 929213901 A GB929213901 A GB 929213901A GB 9213901 A GB9213901 A GB 9213901A GB 9213901 D0 GB9213901 D0 GB 9213901D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title 1
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929213901A GB9213901D0 (en) | 1992-06-30 | 1992-06-30 | Compounds |
| EP93916878A EP0650358A4 (en) | 1992-06-30 | 1993-06-30 | 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors. |
| JP6502657A JPH07508524A (ja) | 1992-06-30 | 1993-06-30 | 5−アルファ−レダクターゼ阻害剤としての17−アシル−4−アザ−ステロイド−3−オン |
| PCT/US1993/006233 WO1994000121A1 (fr) | 1992-06-30 | 1993-06-30 | 17-acyl-4-aza-steroide-3-one a titre d'inhibiteurs de 5-alpha-reductase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929213901A GB9213901D0 (en) | 1992-06-30 | 1992-06-30 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9213901D0 true GB9213901D0 (en) | 1992-08-12 |
Family
ID=10717969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB929213901A Pending GB9213901D0 (en) | 1992-06-30 | 1992-06-30 | Compounds |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0650358A4 (fr) |
| JP (1) | JPH07508524A (fr) |
| GB (1) | GB9213901D0 (fr) |
| WO (1) | WO1994000121A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
| US5595996A (en) * | 1994-10-25 | 1997-01-21 | Merck & Co., Inc. | 7-substituted 4-aza cholanic acid derivatives and their use |
| GB201102913D0 (en) | 2011-02-18 | 2011-04-06 | Univ Birmingham | Novel therapeutic |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
| US4859681A (en) * | 1984-02-27 | 1989-08-22 | Merck & Co., Inc. | 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors |
| US4760071A (en) * | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
| US5049562A (en) * | 1984-02-27 | 1991-09-17 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors |
| GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
| US4888336A (en) * | 1987-01-28 | 1989-12-19 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
| US5110939A (en) * | 1987-01-28 | 1992-05-05 | Smithkline Beecham Corporation | Intermediates in the preparation of steriod 5-alpha-reductase inhibitors |
| US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
| US5116983A (en) * | 1988-04-18 | 1992-05-26 | Merck & Co., Inc. | Dehydrogenation process intermediates |
| US4882319A (en) * | 1988-12-23 | 1989-11-21 | Smithkline Beckman Corporation | Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
| US5098908A (en) * | 1990-06-20 | 1992-03-24 | Merck & Co., Inc. | 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors |
| US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
| US5061803A (en) * | 1990-09-24 | 1991-10-29 | Merck & Co., Inc. | Process for making 17-beta alkanoyl 3-oxo-4-aza-5-α-androst-1-enes |
-
1992
- 1992-06-30 GB GB929213901A patent/GB9213901D0/en active Pending
-
1993
- 1993-06-30 EP EP93916878A patent/EP0650358A4/en not_active Withdrawn
- 1993-06-30 JP JP6502657A patent/JPH07508524A/ja active Pending
- 1993-06-30 WO PCT/US1993/006233 patent/WO1994000121A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994000121A1 (fr) | 1994-01-06 |
| EP0650358A4 (en) | 1995-06-07 |
| EP0650358A1 (fr) | 1995-05-03 |
| JPH07508524A (ja) | 1995-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9300508A0 (en) | Compounds | |
| GB9209628D0 (en) | Compounds | |
| GB9200245D0 (en) | Compounds | |
| GB9201694D0 (en) | Compounds | |
| GB9200209D0 (en) | Compounds | |
| GB9210632D0 (en) | Compounds | |
| GB9210880D0 (en) | Compounds | |
| GB9200566D0 (en) | Compounds | |
| GB9201751D0 (en) | Compounds | |
| GB9202792D0 (en) | Compounds | |
| GB9201692D0 (en) | Compounds | |
| GB9213901D0 (en) | Compounds | |
| GB9205859D0 (en) | Compounds | |
| GB9210659D0 (en) | Compounds | |
| GB9201746D0 (en) | Compounds | |
| GB9203173D0 (en) | Compounds | |
| GB9203172D0 (en) | Compounds | |
| GB9203171D0 (en) | Compounds | |
| GB9203170D0 (en) | Compounds | |
| GB9202991D0 (en) | Compounds | |
| GB9210661D0 (en) | Compounds | |
| GB9206093D0 (en) | Compounds | |
| GB9210660D0 (en) | Compounds | |
| GB9210633D0 (en) | Compounds | |
| GB9201819D0 (en) | Compounds |